Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
A PHASE1 clinical study on Alcohol Use Disorder and PTSD, this trial is ongoing. The trial is conducted by National Institute on Alcohol Abuse and Alcoholism (NIAAA) and has accumulated 15 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Nov 2025 — Present [monthly]
Active Not Recruiting PHASE1
-
Jul 2025 — Nov 2025 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Mar 2025 — Jul 2025 [monthly]
Recruiting PHASE1
-
Dec 2024 — Mar 2025 [monthly]
Recruiting PHASE1
-
Sep 2024 — Dec 2024 [monthly]
Recruiting PHASE1
▶ Show 10 earlier versions
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE1
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE1
-
Nov 2023 — Mar 2024 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Aug 2023 — Nov 2023 [monthly]
Not Yet Recruiting PHASE1
-
Apr 2023 — Aug 2023 [monthly]
Not Yet Recruiting PHASE1
-
Feb 2023 — Apr 2023 [monthly]
Not Yet Recruiting PHASE1
-
Sep 2022 — Feb 2023 [monthly]
Not Yet Recruiting PHASE1
-
Jun 2022 — Sep 2022 [monthly]
Not Yet Recruiting PHASE1
-
Mar 2022 — Jun 2022 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Sage Therapeutics
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .